PUMA BIOTECHNOLOGY, INC. Annual Operating Lease, Payments in USD from 2019 to 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of cash outflow from operating lease, excluding payments to bring another asset to condition and location necessary for its intended use.
Summary
Puma Biotechnology, Inc. quarterly/annual Operating Lease, Payments history and growth rate from 2019 to 2023.
  • Puma Biotechnology, Inc. Operating Lease, Payments for the quarter ending March 31, 2024 was $1.58M, a 5.34% increase year-over-year.
  • Puma Biotechnology, Inc. annual Operating Lease, Payments for 2023 was $6.08M, a 3.79% increase from 2022.
  • Puma Biotechnology, Inc. annual Operating Lease, Payments for 2022 was $5.86M, a 2.29% increase from 2021.
  • Puma Biotechnology, Inc. annual Operating Lease, Payments for 2021 was $5.73M, a 2.91% increase from 2020.
Operating Lease, Payments, Annual (USD)
Operating Lease, Payments, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $6.08M +$222K +3.79% Jan 1, 2023 Dec 31, 2023 10-K 2024-02-29
2022 $5.86M +$131K +2.29% Jan 1, 2022 Dec 31, 2022 10-K 2023-03-02
2021 $5.73M +$162K +2.91% Jan 1, 2021 Dec 31, 2021 10-K 2022-03-03
2020 $5.57M +$131K +2.41% Jan 1, 2020 Dec 31, 2020 10-K 2021-03-01
2019 $5.44M Jan 1, 2019 Dec 31, 2019 10-K 2020-02-28
* An asterisk sign (*) next to the value indicates that the value is likely invalid.